These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35885962)

  • 21. Intracerebral large artery disease in Aicardi-Goutières syndrome with TREX1 mutation: a case report.
    Wu CC; Peng SS; Lee WT
    Neurol Sci; 2020 Nov; 41(11):3353-3356. PubMed ID: 32524323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus.
    Lee-Kirsch MA; Gong M; Chowdhury D; Senenko L; Engel K; Lee YA; de Silva U; Bailey SL; Witte T; Vyse TJ; Kere J; Pfeiffer C; Harvey S; Wong A; Koskenmies S; Hummel O; Rohde K; Schmidt RE; Dominiczak AF; Gahr M; Hollis T; Perrino FW; Lieberman J; Hübner N
    Nat Genet; 2007 Sep; 39(9):1065-7. PubMed ID: 17660818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond.
    Livingston JH; Crow YJ
    Neuropediatrics; 2016 Dec; 47(6):355-360. PubMed ID: 27643693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulation of the immune system in Aicardi-Goutières syndrome: another example in a TREX1-mutated patient.
    Olivieri I; Cattalini M; Tonduti D; La Piana R; Uggetti C; Galli J; Meini A; Tincani A; Moratto D; Fazzi E; Balottin U; Orcesi S
    Lupus; 2013 Sep; 22(10):1064-9. PubMed ID: 23918923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A homozygous NOTCH3 mutation p.R544C and a heterozygous TREX1 variant p.C99MfsX3 in a family with hereditary small vessel disease of the brain.
    Soong BW; Liao YC; Tu PH; Tsai PC; Lee IH; Chung CP; Lee YC
    J Chin Med Assoc; 2013 Jun; 76(6):319-24. PubMed ID: 23602593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Typing TREX1 gene in patients with systemic lupus erythematosus.
    Fredi M; Bianchi M; Andreoli L; Greco G; Olivieri I; Orcesi S; Fazzi E; Cereda C; Tincani A
    Reumatismo; 2015 Jun; 67(1):1-7. PubMed ID: 26150267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases.
    Gao D; Li T; Li XD; Chen X; Li QZ; Wight-Carter M; Chen ZJ
    Proc Natl Acad Sci U S A; 2015 Oct; 112(42):E5699-705. PubMed ID: 26371324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and molecular phenotype of Aicardi-Goutieres syndrome.
    Rice G; Patrick T; Parmar R; Taylor CF; Aeby A; Aicardi J; Artuch R; Montalto SA; Bacino CA; Barroso B; Baxter P; Benko WS; Bergmann C; Bertini E; Biancheri R; Blair EM; Blau N; Bonthron DT; Briggs T; Brueton LA; Brunner HG; Burke CJ; Carr IM; Carvalho DR; Chandler KE; Christen HJ; Corry PC; Cowan FM; Cox H; D'Arrigo S; Dean J; De Laet C; De Praeter C; Dery C; Ferrie CD; Flintoff K; Frints SG; Garcia-Cazorla A; Gener B; Goizet C; Goutieres F; Green AJ; Guet A; Hamel BC; Hayward BE; Heiberg A; Hennekam RC; Husson M; Jackson AP; Jayatunga R; Jiang YH; Kant SG; Kao A; King MD; Kingston HM; Klepper J; van der Knaap MS; Kornberg AJ; Kotzot D; Kratzer W; Lacombe D; Lagae L; Landrieu PG; Lanzi G; Leitch A; Lim MJ; Livingston JH; Lourenco CM; Lyall EG; Lynch SA; Lyons MJ; Marom D; McClure JP; McWilliam R; Melancon SB; Mewasingh LD; Moutard ML; Nischal KK; Ostergaard JR; Prendiville J; Rasmussen M; Rogers RC; Roland D; Rosser EM; Rostasy K; Roubertie A; Sanchis A; Schiffmann R; Scholl-Burgi S; Seal S; Shalev SA; Corcoles CS; Sinha GP; Soler D; Spiegel R; Stephenson JB; Tacke U; Tan TY; Till M; Tolmie JL; Tomlin P; Vagnarelli F; Valente EM; Van Coster RN; Van der Aa N; Vanderver A; Vles JS; Voit T; Wassmer E; Weschke B; Whiteford ML; Willemsen MA; Zankl A; Zuberi SM; Orcesi S; Fazzi E; Lebon P; Crow YJ
    Am J Hum Genet; 2007 Oct; 81(4):713-25. PubMed ID: 17846997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial chilblain lupus due to a novel mutation in TREX1 associated with Aicardi-Goutie'res syndrome.
    Yi C; Li Q; Xiao J
    Pediatr Rheumatol Online J; 2020 Apr; 18(1):32. PubMed ID: 32293470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in the non-catalytic polyproline motif destabilize TREX1 and amplify cGAS-STING signaling.
    Shim A; Luan X; Zhou W; Crow Y; Maciejowski J
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling of TREX1-Dependent Autoimmune Disease using Human Stem Cells Highlights L1 Accumulation as a Source of Neuroinflammation.
    Thomas CA; Tejwani L; Trujillo CA; Negraes PD; Herai RH; Mesci P; Macia A; Crow YJ; Muotri AR
    Cell Stem Cell; 2017 Sep; 21(3):319-331.e8. PubMed ID: 28803918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the non-catalytic polyproline motif destabilize TREX1 and amplify cGAS-STING signaling.
    Shim A; Luan X; Zhou W; Crow YJ; Maciejowski J
    Hum Mol Genet; 2024 Sep; 33(18):1555-1566. PubMed ID: 38796715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinib.
    Zhang S; Song J; Yang Y; Miao H; Yang L; Liu Y; Zhang X; Liu Y; Wang T
    Pediatr Rheumatol Online J; 2021 Jan; 19(1):1. PubMed ID: 33407657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic variation in Aicardi-Goutières syndrome explained by cell-specific IFN-stimulated gene response and cytokine release.
    Cuadrado E; Michailidou I; van Bodegraven EJ; Jansen MH; Sluijs JA; Geerts D; Couraud PO; De Filippis L; Vescovi AL; Kuijpers TW; Hol EM
    J Immunol; 2015 Apr; 194(8):3623-33. PubMed ID: 25769924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome.
    Ramantani G; Kohlhase J; Hertzberg C; Innes AM; Engel K; Hunger S; Borozdin W; Mah JK; Ungerath K; Walkenhorst H; Richardt HH; Buckard J; Bevot A; Siegel C; von Stülpnagel C; Ikonomidou C; Thomas K; Proud V; Niemann F; Wieczorek D; Häusler M; Niggemann P; Baltaci V; Conrad K; Lebon P; Lee-Kirsch MA
    Arthritis Rheum; 2010 May; 62(5):1469-77. PubMed ID: 20131292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of Aicardi-Goutières syndrome caused by TREX1 gene mutation.
    Chenhan Z; Jun S; Yang D; Linliang Y; Xiaowen G; Chunya J; Xuedong D
    BMC Pregnancy Childbirth; 2023 Feb; 23(1):124. PubMed ID: 36814213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical properties of mammalian TREX1 and its association with DNA replication and inherited inflammatory disease.
    Lindahl T; Barnes DE; Yang YG; Robins P
    Biochem Soc Trans; 2009 Jun; 37(Pt 3):535-8. PubMed ID: 19442247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice.
    Sakai T; Miyazaki T; Shin DM; Kim YS; Qi CF; Fariss R; Munasinghe J; Wang H; Kovalchuk AL; Kothari PH; Fermaintt CS; Atkinson JP; Perrino FW; Yan N; Morse HC
    J Autoimmun; 2017 Jul; 81():13-23. PubMed ID: 28325644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TREX1 is required for microglial cholesterol homeostasis and oligodendrocyte terminal differentiation in human neural assembloids.
    Goldberg G; Coelho L; Mo G; Adang LA; Patne M; Chen Z; Garcia-Bassets I; Mesci P; Muotri AR
    Mol Psychiatry; 2024 Mar; 29(3):566-579. PubMed ID: 38129659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity.
    Crow YJ; Rehwinkel J
    Hum Mol Genet; 2009 Oct; 18(R2):R130-6. PubMed ID: 19808788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.